SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice
SHANK2 (ProSAP1) is a postsynaptic scaffolding protein of excitatory synapses in the central nervous system and implicated in the development of autism spectrum disorders (ASD). Patients with mutations in SHANK2 show autism-like behaviors, developmental delay, and intellectual disability. We generat...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/62de73e79ade401bb205c8be84ad16a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:62de73e79ade401bb205c8be84ad16a1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:62de73e79ade401bb205c8be84ad16a12021-12-01T08:00:15ZSHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice1662-509910.3389/fnmol.2021.773571https://doaj.org/article/62de73e79ade401bb205c8be84ad16a12021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnmol.2021.773571/fullhttps://doaj.org/toc/1662-5099SHANK2 (ProSAP1) is a postsynaptic scaffolding protein of excitatory synapses in the central nervous system and implicated in the development of autism spectrum disorders (ASD). Patients with mutations in SHANK2 show autism-like behaviors, developmental delay, and intellectual disability. We generated human induced pluripotent stem cells (hiPSC) from a patient carrying a heterozygous deletion of SHANK2 and from the unaffected parents. In patient hiPSCs and derived neurons SHANK2 mRNA and protein expression was reduced. During neuronal maturation, a reduction in growth cone size and a transient increase in neuronal soma size were observed. Neuronal proliferation was increased, and apoptosis was decreased in young and mature neurons. Additionally, mature patient hiPSC-derived neurons showed dysregulated excitatory signaling and a decrease of a broad range of signaling molecules of the ERK-MAP kinase pathway. These findings could be confirmed in brain samples from Shank2(−/−) mice, which also showed decreased mGluR5 and phospho-ERK1/2 expression. Our study broadens the current knowledge of SHANK2-related ASD. We highlight the importance of excitatory-inhibitory balance and mGluR5 dysregulation with disturbed downstream ERK1/2 signaling in ASD, which provides possible future therapeutic strategies for SHANK2-related ASD.Anne-Kathrin LutzAndrea Pérez ArévaloValentin IoannidisNadine StirmlingerMaria DemestreRichard DelormeThomas BourgeronTobias M. BoeckersTobias M. BoeckersFrontiers Media S.A.articleSHANK2hiPSCsERK1/2neurodevelopmentASDNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Molecular Neuroscience, Vol 14 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
SHANK2 hiPSCs ERK1/2 neurodevelopment ASD Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 |
spellingShingle |
SHANK2 hiPSCs ERK1/2 neurodevelopment ASD Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Anne-Kathrin Lutz Andrea Pérez Arévalo Valentin Ioannidis Nadine Stirmlinger Maria Demestre Richard Delorme Thomas Bourgeron Tobias M. Boeckers Tobias M. Boeckers SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice |
description |
SHANK2 (ProSAP1) is a postsynaptic scaffolding protein of excitatory synapses in the central nervous system and implicated in the development of autism spectrum disorders (ASD). Patients with mutations in SHANK2 show autism-like behaviors, developmental delay, and intellectual disability. We generated human induced pluripotent stem cells (hiPSC) from a patient carrying a heterozygous deletion of SHANK2 and from the unaffected parents. In patient hiPSCs and derived neurons SHANK2 mRNA and protein expression was reduced. During neuronal maturation, a reduction in growth cone size and a transient increase in neuronal soma size were observed. Neuronal proliferation was increased, and apoptosis was decreased in young and mature neurons. Additionally, mature patient hiPSC-derived neurons showed dysregulated excitatory signaling and a decrease of a broad range of signaling molecules of the ERK-MAP kinase pathway. These findings could be confirmed in brain samples from Shank2(−/−) mice, which also showed decreased mGluR5 and phospho-ERK1/2 expression. Our study broadens the current knowledge of SHANK2-related ASD. We highlight the importance of excitatory-inhibitory balance and mGluR5 dysregulation with disturbed downstream ERK1/2 signaling in ASD, which provides possible future therapeutic strategies for SHANK2-related ASD. |
format |
article |
author |
Anne-Kathrin Lutz Andrea Pérez Arévalo Valentin Ioannidis Nadine Stirmlinger Maria Demestre Richard Delorme Thomas Bourgeron Tobias M. Boeckers Tobias M. Boeckers |
author_facet |
Anne-Kathrin Lutz Andrea Pérez Arévalo Valentin Ioannidis Nadine Stirmlinger Maria Demestre Richard Delorme Thomas Bourgeron Tobias M. Boeckers Tobias M. Boeckers |
author_sort |
Anne-Kathrin Lutz |
title |
SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice |
title_short |
SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice |
title_full |
SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice |
title_fullStr |
SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice |
title_full_unstemmed |
SHANK2 Mutations Result in Dysregulation of the ERK1/2 Pathway in Human Induced Pluripotent Stem Cells-Derived Neurons and Shank2(−/−) Mice |
title_sort |
shank2 mutations result in dysregulation of the erk1/2 pathway in human induced pluripotent stem cells-derived neurons and shank2(−/−) mice |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/62de73e79ade401bb205c8be84ad16a1 |
work_keys_str_mv |
AT annekathrinlutz shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT andreaperezarevalo shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT valentinioannidis shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT nadinestirmlinger shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT mariademestre shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT richarddelorme shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT thomasbourgeron shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT tobiasmboeckers shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice AT tobiasmboeckers shank2mutationsresultindysregulationoftheerk12pathwayinhumaninducedpluripotentstemcellsderivedneuronsandshank2mice |
_version_ |
1718405415219232768 |